Manatt Helps Heluna Health Resolve $370 Million CDC Audit

Manatt successfully represented Heluna Health in resolving a federal audit of its COVID-19 response funding, eliminating a potential repayment of $370 million to the Centers for Disease Control and Prevention (CDC).

A 2024 audit by the U.S. Department of Health and Human Services Office of Inspector General reviewed $588 million in expenditures from 2020-2021. Following the audit, Heluna Health faced a potential reimbursement of $370 million.

Heluna Health and Manatt worked together to appeal the initial determination and submitted documentation demonstrating the appropriate use and distribution of the funds. Upon review, the CDC reduced the amount at issue to $20.8 million in July 2026. Heluna Health appealed the remaining amount, and following a site visit in September, the CDC recommended full resolution of the disallowed costs and closed the investigation.  

The Manatt team was led by Partner and Government and Regulatory Leader , Partner and Leader of Manatt Health and Government and Regulatory Associate